Alejandra Contreras-Manzano1, Carlos M Guerrero-López2, Mercedes Aguerrebere3, Ana Cristina Sedas4, Héctor Lamadrid-Figueroa5. 1. Center for Nutrition and Health Research, National Institute of Public Health, Cuernavaca, Morelos, Mexico. 2. Mexican Social Security Institute, Juárez, Cuauhtémoc, Mexico. 3. National Autonomous University of Mexico, Mexico City, Mexico. 4. Department of Global Health and Social Medicine, Harvard Medical School, Boston, MassachusettsUSA. 5. Center for Population Health Research, National Institute of Public Health, Cuernavaca, Morelos, Mexico.
Abstract
OBJECTIVE: Local characteristics of populations have been associated with coronavirus disease 2019 (COVID-19) outcomes. We analyze the municipality-level factors associated with a high COVID-19 mortality rate (MR) of in Mexico. METHODS: We retrieved information from cumulative confirmed symptomatic cases and deaths from COVID-19 as of June 20, 2020, and data from most recent census and surveys of Mexico. A negative binomial regression model was adjusted, the dependent variable was the number of COVID-19 deaths, and the independent variables were the quintiles of the distribution of sociodemographic and health characteristics among the 2457 municipalities of Mexico. RESULTS: Factors associated with high MRs from COVID-19, relative to quintile 1, were diabetes and obesity prevalence, diabetes mortality rate, indigenous population, economically active population, density of economic units that operate essential activities, and population density. Among factors inversely associated with lower MRs from COVID-19 were high hypertension prevalence and houses without sewage drainage. We identified 1351 municipalities without confirmed COVID-19 deaths, of which, 202 had high and 82 very high expected COVID-19 mortality (mean = 8 and 13.8 deaths per 100,000, respectively). CONCLUSION: This study identified municipalities of Mexico that could lead to a high mortality scenario later in the epidemic and warns against premature easing of mobility restrictions and to reinforce strategies of prevention and control of outbreaks in communities vulnerable to COVID-19.
OBJECTIVE: Local characteristics of populations have been associated with coronavirus disease 2019 (COVID-19) outcomes. We analyze the municipality-level factors associated with a high COVID-19mortality rate (MR) of in Mexico. METHODS: We retrieved information from cumulative confirmed symptomatic cases and deaths from COVID-19 as of June 20, 2020, and data from most recent census and surveys of Mexico. A negative binomial regression model was adjusted, the dependent variable was the number of COVID-19deaths, and the independent variables were the quintiles of the distribution of sociodemographic and health characteristics among the 2457 municipalities of Mexico. RESULTS: Factors associated with high MRs from COVID-19, relative to quintile 1, were diabetes and obesity prevalence, diabetes mortality rate, indigenous population, economically active population, density of economic units that operate essential activities, and population density. Among factors inversely associated with lower MRs from COVID-19 were high hypertension prevalence and houses without sewage drainage. We identified 1351 municipalities without confirmed COVID-19deaths, of which, 202 had high and 82 very high expected COVID-19mortality (mean = 8 and 13.8 deaths per 100,000, respectively). CONCLUSION: This study identified municipalities of Mexico that could lead to a high mortality scenario later in the epidemic and warns against premature easing of mobility restrictions and to reinforce strategies of prevention and control of outbreaks in communities vulnerable to COVID-19.
Entities:
Keywords:
COVID-19; health determinants; municipality-level; risk factors; social determinants
Authors: Daniel Pan; Shirley Sze; Jatinder S Minhas; Mansoor N Bangash; Nilesh Pareek; Pip Divall; Caroline Ml Williams; Marco R Oggioni; Iain B Squire; Laura B Nellums; Wasim Hanif; Kamlesh Khunti; Manish Pareek Journal: EClinicalMedicine Date: 2020-06-03
Authors: Margaret E Kruk; Anna D Gage; Naima T Joseph; Goodarz Danaei; Sebastián García-Saisó; Joshua A Salomon Journal: Lancet Date: 2018-09-05 Impact factor: 79.321
Authors: Stefan R Bornstein; Francesco Rubino; Kamlesh Khunti; Geltrude Mingrone; David Hopkins; Andreas L Birkenfeld; Bernhard Boehm; Stephanie Amiel; Richard Ig Holt; Jay S Skyler; J Hans DeVries; Eric Renard; Robert H Eckel; Paul Zimmet; Kurt George Alberti; Josep Vidal; Bruno Geloneze; Juliana C Chan; Linong Ji; Barbara Ludwig Journal: Lancet Diabetes Endocrinol Date: 2020-04-23 Impact factor: 32.069